IP Library › Granted Patent US 8,367,683
Granted Patent B2
US 8,367,683 · App. 12/689,367 · Granted Feb 5, 2013

Composition and method for treatment of warts

Inventor: Craig Herman (Conrad, IA)
Assignee: Medcara, L.L.C.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,367,683
App. No.
12/689,367
Granted
Feb 5, 2013
Kind
B2
Abstract

Provided is a composition comprising 5-FU and salicylic acid. This composition is useful as a treatment for warts. As opposed to conventional compositions and methods, this composition need only be applied once a day. Also provided are methods for the preparation and use of the composition for treatment of warts.

Claims (6)

1. A composition for treatment of warts comprising: from 0.5 to 5.0% by weight 5-fluorouracil (5-FU); from 10.0 to 25.0% by weight salicylic acid; from 5 to 50% by weight of DMSO; from 1-10% by weight of a water-swellable polymer; and from 10-75% by weight of an adhesive; whereby the composition is a sustained release topical gel, said composition being acidic.

2. A composition for treatment of warts comprising: from 0.5 to 5.0% by weight 5-fluorouracil (5-FU); from 10.0 to 25.0% by weight salicylic acid; from 5 to 50% by weight of organic solvent; from 1-10% by weight of a water-swellable polymer; and from 10-75% by weight of an adhesive; whereby the composition is a sustained release topical gel, said composition being acidic.

3. A composition for treatment of warts comprising: from 0.5 to 5.0% by weight 5-fluorouracil (5-FU); from 10.0 to 25.0% by weight salicylic acid; from 5 to 50% by weight of organic solvent; from 1-10% by weight of a water-swellable polymer; and from 10-75% by weight of an adhesive; said composition being acidic.

4. The composition of claim 1 further including from 0.4 to 2.0% by weight lecithin; and further providing that the adhesive is polyvinyl alcohol gel.

5. The composition of claim 1 comprising 2-5% by weight 5-FU.

6. The composition of claim 1 comprising 2% by weight 5-FU.

Assignments (2)
CHANGE OF NAME Recorded Sep 2, 2011
From: NUCARA PHARMACEUTICAL, L.LC.
To: MEDCARA, L.L.C.
Reel/Frame 026855/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2011
From: HERMAN, CRAIG
To: NUCARA PHARMACEUTICAL, L.C.
Reel/Frame 026842/0515 →
Continuity (2)
Continuation 11037403 · Jan 18, 2005
Related Publication 20100190810A1 · Jul 29, 2010